FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
SME IPO Status: Closed [15th May 2024 to 17th May 2024]
Quest Laboratories IPO, a SME IPO of ₹43.16 Cr opens for subscription from 15-05-2024 to 17-05-2024. The IPO consists of ₹43.16 Cr fresh issue.
The face value is Rs 10 and the price band is fixed at 93.00-97.00 per share. You can apply to the Quest Laboratories SME IPO for a minimum lot of 1200 shares amounting of Rs 116400.
The tentative listing date on the exchange (NSE SME) is 23-05-2024.Stay tuned with us to get more details about Quest Laboratories SME IPO including business overview, financial performance, live subscription status, allotment details, daily grey market premium (GMP), listing date, and listing price.
SME IPO Issue Opening Date: | 15th May 2024 |
SME IPO Issue Closing Date: | 17th May 2024 |
SME IPO Issue Price: | ₹93.00-97.00 Per Share |
DRHP: | Download DRHP |
RHP: | Download RHP |
Anchor List: | Download Anchor List |
IPO Listing At: | NSE SME |
Retail Quota: | Not less than 35% of the Net Issue |
SME IPO Issue Type: | Book Build Issue |
SME IPO Issue Size: | ₹43.16 Cr |
Fresh Issue: | ₹43.16 Cr |
Face Value: | ₹10 Per Equity Share |
SME IPO Discount: | TBD |
Promoter Holding Pre IPO: | 90.36% |
Promoter Holding Post IPO: | 65.82% |
Get important updates regarding Quest Laboratories SME IPO tentative timeline covering SME IPO opening, closing, allotment, and listing dates. Dates are updated as they are announced.
SME IPO Activity | Date |
---|---|
Basis of Allotment Date* | 21st May 2024 |
Refunds Initiation* | 22nd May 2024 |
Credit of Shares to Demat* | 22nd May 2024 |
SME IPO Listing Date* | 23rd May 2024 |
* - Tentative Dates
SME IPO Activity | Date |
---|---|
Issue Price | ₹93.00-97.00 |
Market Lot: | 1200 Shares |
1 Lot Amount: | ₹116400 |
Min HNI Lots: | 2400 shares (2 lots) |
GMP Date | IPO Price | GMP | Sub2 Sauda Rate | Expected Listing Gain | Last Updated |
---|---|---|---|---|---|
20-05-2024 | 97.00 | 54 | 49200 | ₹151 (55.67%) | 20-May-2024 15:58 |
**The GMP prices shown here are only news related to the grey market. We do not trade/deal in grey market or subject to rates (sub2), nor do we recommend trading in grey market.
Quest Laboratories Limited was established in 1998 and is engaged in the manufacture of pharmaceutical formulations across a wide spectrum including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antimetics, respiratory drugs, diabetes, treatments, antidepressants and more. These formulations fall under the “Quest Laboratories Limited” brand. The company manufactures a variety of products including ethical medicines, generic medicines and over-the-counter medicines. These products are available in various forms such as tablets, liquid medicines, oral dry powders, oral release powders (ORS), ointments and topical liquids. This comprehensive approach enables the company to cover a wide range of medical needs and patient preferences.
The company also holds a Good Laboratory Practice (GLP) certificate issued by the Food & Drug Administration, Bhopal, Madhya Pradesh, underlining its commitment to maintaining high standards of quality and compliance in laboratory operations, especially in the pharmaceutical sector. The in-house laboratory is equipped with various instruments such as HPLC (High Performance Liquid Chromatography), GC (Gas Chromatography), FTIR (Fourier Transform Infrared Spectroscopy), UV (Ultraviolet Spectroscopy), dissolution devices and other advanced instruments. With this comprehensive range of instruments, we are able to perform a wide range of tests and analysis efficiently and accurately.
The Company operates in the domestic market in twelve (12) states and two (2) Union Territories, namely Uttar Pradesh, Madhya Pradesh, Maharashtra, Delhi, Jharkhand, Assam, Karnataka, Jammu & Kashmir, Rajasthan, West Bengal, Gujarat, Telangana, Haryana and Bihar, based on revenue for the period ended December 31, 2023 and for the year ended December 31, 2023. December 2023 and for the financial year ending December 31, 2023 and for the financial year ending December 31, 2023 and for the financial year ending December 31, 2023 and for the financial year ending December 31, 2023. Based on turnover for the period ending December 31, 2023 and for the financial year ending March 31, 2023, 2022 and 2021.
This company regularly receives orders from the private sector and government agencies. This collaborative approach offers buyers benefits such as cost efficiencies through mass production, capacity expansion, regulatory compliance, shorter lead times, risk mitigation, access to specialized technologies, geographic expansion, cost-effective regulatory compliance and resource optimization.
Incorporation | Sector | IPO Issue Size | Website |
1998 | Pharmaceuticals | ₹43.16 Cr | https://www.questlabltd.com/ |
The company proposes to utilize the Net Proceeds from the Issue towards funding the following objects:
Our experts can help you prepare for SME IPO
The table below is live update of SME IPO bidding details from NSE and BSE.
Day | QIB | NII | RII | Total | |
---|---|---|---|---|---|
# of Shares Offered | 831,600 (27.85%) | 655,200 (21.95%) | 1,498,800 (50.2%) | 2,985,600 | |
1 | 15th May 2024 19:31 | 0.01x | 0.76x | 2.17x | 1.26x |
2 | 16th May 2024 19:31 | 0.01x | 2.39x | 6.34x | 3.71x |
3 | 17th May 2024 18:21 | 57.20x | 184.10x | 57.63x | 85.26x |
Quest Laboratories Limited's revenue increased by 3.9% and profit after tax (PAT) rose by 22.5% between the financial year ending with March 31, 2023 and March 31, 2022.
Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
Assets | 5,869.09 | 4,664.72 | 3,479.86 | 1,839.63 |
Revenue | 6,217.83 | 6,186.60 | 5,954.20 | 3,043.55 |
Profit After Tax | 774.93 | 502.85 | 410.50 | 65.50 |
Net Worth | 2,277.15 | 1,502.21 | 999.38 | 588.84 |
Reserves and Surplus | 1,198.39 | 1,394.33 | 891.50 | 480.96 |
Total Borrowing | 460.66 | 409.69 | 312.54 | 304.03 |
Amount in ₹ Lakhs |
The table below show peer comparison from DRHP/RHP.
Company | EPS Basic | EPS Diluted | NAV | P/E(x) | RoNW | Financial statements |
---|---|---|---|---|---|---|
Quest Laboratories Limited | 4.66 | 4.66 | 13.93 | 33.47 | ||
Beta Drugs Limited | 19.57 | 19.57 | 100.12 | 66.43 | 19.55 | Standalone |
Alpa Laboratories Ltd. | 5.9 | 5.9 | 68.69 | 15.92 | 8.59 | Standalone |
Zenith Drugs Limited | 4.29 | 4.29 | 14.37 | 14.69 | 29.88 | Consolidated |
Last Updated on 20-May-2024 15:32:50
Zerodha allows to apply online in IPOs via their back office software "console". UPI payment mode is to be used to apply online through Zerodha. To purchase Quest Laboratories SME IPO with Zerodha, you must be Zerodha customer and have UPI payment setup. For more details please visit detailed article Step by Step Guide to apply Quest Laboratories SME IPO with Zerodha.
Alternate approch to apply in Quest Laboratories SME IPO is ASBA. You can use Zerodha DP information and apply online via ASBA with your prefered net banking user id.
Quest Laboratories SME IPO Review and Important Updates
Other relevant questions :
How to subscribe Quest Laboratories SME IPO Zerodha? How to purchase Quest Laboratories SME IPO on Zerodha? Quest Laboratories SME IPO how to buy Zerodha? Quest Laboratories SME IPO Zerodha apply. Quest Laboratories SME IPO purchase Zerodha. Quest Laboratories SME IPO with Zerodha. Quest Laboratories SME IPO at Zerodha. Quest Laboratories SME IPO kite Zerodha. Quest Laboratories SME IPO using Zerodha. Quest Laboratories SME IPO via Zerodha.
To subscribe or apply in Quest Laboratories SME IPO, you can use the following methods:
Quest Laboratories SME IPO Applying Mode | Method | Details |
Online Application | 3-in-1 Trading Account | If your broker is 3-in-1 service provider, you can apply in Quest Laboratories SME IPO directly with your brokers website. Example HDFC Sky, ICICI Direct, AxisDirect are 3-in-1 brokers provide you direct IPO investment. |
Online Application | 2-in-1 Trading Account | Brokers like Zerodha, TradeSmart Online provides access to applying in Quest Laboratories SME IPO with their in-house developed platform. You need to apply in IPO via UPI payment method. You must have access of your UPI mandate to apply in IPO online. |
Online Application | ASBA | This is one of the most popular mode of applying in Quest Laboratories SME IPO. Most of the Syndicate Banks provide access to apply in Quest Laboratories IPO via ASBA process. You must have your net banking access, DP ID information to apply in Quest Laboratories SME IPO via ASBA. Bank like Axis, SBI allows you to apply maximum 5 application from one bank account. However, ICICI, HDFC bank have limit of one IPO ASBA application per account. |
Offline Application | Physical Form | You can apply in Quest Laboratories SME IPO via physical form, but not with ASBA. Physical Forms need to be filled using UPI mode of payment and need to approve the mandate of UPI with your registered phone number with your UPI provider. You can use BHIM app or banks mobile app who support UPI process like SBI, HSBC, Axis, ICICI, HDFC, Yes Bank, Citi Bank mobile app. |
Quest Laboratories SME IPO Review and Important Updates
Other relevant question on same topics are:
Where to subscribe Quest Laboratories SME IPO? Where to apply for Quest Laboratories SME IPO? How to subscribe Quest Laboratories SME IPO online? Quest Laboratories SME IPO where to apply? Where to buy Quest Laboratories SME IPO online? How to buy Quest Laboratories SME IPO online? How to purchase Quest Laboratories SME IPO? How to get Quest Laboratories SME IPO? How to book Quest Laboratories SME IPO? How to invest Quest Laboratories SME IPO? Quest Laboratories SME IPO kaise buy kare?
Quest Laboratories SME IPO is going to be list on 23-05-2024.
Other relevant questions:
When Quest Laboratories SME IPO will be listing? Quest Laboratories SME IPO listing date?Quest Laboratories SME IPO date of listing
Quest Laboratories SME IPO Allotment Date is 21-05-2024.
Other relevant questions:
Quest Laboratories SME IPO share allotment date?Quest Laboratories SME IPO allotment date?